2023 - Research.com Medicine in France Leader Award
2023 - Research.com Immunology in France Leader Award
Member of the European Molecular Biology Organization (EMBO)
His main research concerns Immunology, Cell biology, Natural killer cell, Interleukin 21 and Lymphokine-activated killer cell. The Immunology study combines topics in areas such as Stromal cell, Cancer research and Transcription factor. His Cell biology study integrates concerns from other disciplines, such as Cell, Dendritic cell, Interferon gamma, NKG2D and MHC class I.
Eric Vivier has researched Natural killer cell in several fields, including Receptor, Innate immune system and Cell growth. Eric Vivier combines subjects such as Molecular biology, Cellular differentiation, Interleukin 15 and Bone marrow with his study of Interleukin 21. In his study, Cytokine secretion is inextricably linked to NK-92, which falls within the broad field of Lymphokine-activated killer cell.
Eric Vivier mostly deals with Immunology, Cell biology, Natural killer cell, Receptor and Interleukin 21. His Immunology study frequently involves adjacent topics like Cytotoxic T cell. Eric Vivier focuses mostly in the field of Cell biology, narrowing it down to matters related to T cell and, in some cases, CD8.
His Natural killer cell research is multidisciplinary, incorporating perspectives in Molecular biology and Dendritic cell. His biological study spans a wide range of topics, including Tyrosine, MHC class I and Antibody. His Interleukin 21 research incorporates themes from Interleukin 12, IL-2 receptor and Antigen-presenting cell.
Eric Vivier mainly investigates Innate lymphoid cell, Immunology, Cancer research, Immune system and Cell biology. His study on Innate lymphoid cell is covered under Immunity. As part of the same scientific family, he usually focuses on Immunology, concentrating on Disease and intersecting with Complement system.
His Cancer research research incorporates elements of Cell, Cytotoxic T cell, Antibody and Cancer. His Immune system research is multidisciplinary, relying on both Myeloid, Immunosuppression, Interleukin 12 and Monoclonal antibody. His Cell biology research includes themes of Receptor and Cytokine.
His primary areas of investigation include Immunity, Innate lymphoid cell, Cancer research, Immune system and Cell biology. Eric Vivier interconnects Acquired immune system, Cell type, Innate immune system, Neuroscience and Immunotherapy in the investigation of issues within Immunity. His Innate immune system study is concerned with Immunology in general.
The various areas that Eric Vivier examines in his Innate lymphoid cell study include Spleen and Homeostasis. In general Cell biology, his work in Signal transduction is often linked to Context linking many areas of study. His study looks at the relationship between Cytotoxic T cell and fields such as T cell, as well as how they intersect with chemical problems.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Functions of natural killer cells
Eric Vivier;Elena Tomasello;Elena Tomasello;Myriam Baratin;Myriam Baratin;Thierry Walzer;Thierry Walzer.
Nature Immunology (2008)
Innate or Adaptive Immunity? The Example of Natural Killer Cells
Eric Vivier;David H. Raulet;Alessandro Moretta;Michael A. Caligiuri.
Science (2011)
Innate lymphoid cells--a proposal for uniform nomenclature.
Hergen Spits;David Artis;Marco Colonna;Andreas Diefenbach.
Nature Reviews Immunology (2013)
The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide
Sophie Viaud;Sophie Viaud;Fabiana Saccheri;Grégoire Mignot;Takahiro Yamazaki.
Science (2013)
Human NK Cell Education by Inhibitory Receptors for MHC Class I
Nicolas Anfossi;Pascale André;Sophie Guia;Sophie Guia;Christine S Falk.
Immunity (2006)
TLR3 deficiency in patients with herpes simplex encephalitis.
Shen Ying Zhang;Shen Ying Zhang;Emmanuelle Jouanguy;Emmanuelle Jouanguy;Sophie Ugolini;Asma Smahi.
Science (2007)
Innate Lymphoid Cells: 10 Years On.
Eric Vivier;David Artis;Marco Colonna;Andreas Diefenbach.
Cell (2018)
CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner
Francois Ghiringhelli;Cédric Ménard;Magali Terme;Caroline Flament.
Journal of Experimental Medicine (2005)
Targeting natural killer cells and natural killer T cells in cancer.
Eric Vivier;Sophie Ugolini;Didier Blaise;Christian Chabannon.
Nature Reviews Immunology (2012)
Natural killer cell signaling pathways.
Eric Vivier;Jacques A. Nunès;Frédéric Vély.
Science (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Inserm
Claude Bernard University Lyon 1
Centre d’Immunologie de Marseille-Luminy
Monash University
Université Paris Cité
University of Genoa
University of Paris-Saclay
Aix-Marseille University
University of Queensland
Necker-Enfants Malades Hospital
Microsoft (United States)
IBM (United States)
National Institute for Materials Science
University of Turin
Monsanto (United States)
The University of Texas Health Science Center at San Antonio
Weizmann Institute of Science
University of York
University of Cologne
University of Oslo
Chinese Academy of Sciences
University of Göttingen
University of Denver
San Diego State University
University of Helsinki
The University of Texas at Austin